(Q80609691)
Statements
Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys (English)
Xuebing Cao
Li Liang
Philip A Iredale
Stewart Factor